Primary Health Properties PLC

Report Publication Announcement • Jan 16, 2023

National Storage Mechanism | Additional information

RNS Number : 7289M

Primary Health Properties PLC

16 January 2023

16 January 2023

Primary Health Properties PLC

Notice of Preliminary Results

Primary Health Properties PLC (LSE: PHP), one of the UK's leading investors in modern primary healthcare facilities, will announce its preliminary results for the year ended 31 December 2022 on Wednesday, 22 February 2023.

A presentation for analysts will be held at Buchanan Communications on the day of results at 9.30am and will also be accessible via live video webcast and a live conference call facility. Following the presentation there will be a moderated Q&A session.

To access the briefing, please log on or dial in shortly before 09.30am via the details below:

Webcast: https://stream.brrmedia.co.uk/broadcast/63c1667fddbb3277238eaa71

Tel: +44 (0) 33 0551 0200

Password: Quote "PHP results" when prompted

If you would like to register your interest in attending the meeting, please contact Buchanan at php@buchanan.uk.com.

A recording of the webcast will be made available from c.12.00pm on 22 February on the PHP website, https://www.phpgroup.co.uk/.

-Ends-

Further details:

Harry Hyman Chief Executive Officer Tel: 07973 344 768	Richard Howell Chief Financial Officer Tel: 0776 6072 272
David Rydell / Jamie Hooper / Hannah Ratcliff / Verity Parker Buchanan Communications Tel: +44 (0) 20 7466 5066

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORBJMFTMTBBBMJ